![](/img/cover-not-exists.png)
A phase II study of epigenetic therapy with hydralazine and magnesium valproate to overcome chemotherapy resistance in refractory solid tumors
Candelaria, M, Gallardo-Rincon, D, Arce, C, Cetina, L, Aguilar-Ponce, J., Arrieta, O, Gonzalez-Fierro, A, Chavez-Blanco, A, de la Cruz-Hernandez, E, Camargo, M., Trejo-Becerril, C, Perez-Cardenas, E,Volume:
18
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdm204
Date:
August, 2007
File:
PDF, 290 KB
english, 2007